Merit medical's wrapsody wave trial demonstrates superior patency versus standard of care in av fistula patients

In the us pivotal trial, wrapsody achieved 89.8% target lesion primary patency at 6 months in the us pivotal trial, wrapsody achieved 89.8% target lesion primary patency at 6 months

WAVE Ratings Summary

WAVE Quant Ranking